Sun J. Cha
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Carboplatin alleviates astrocytic TDP-43 neurotoxicity by inhibiting NF-κB activation.
Journal: European journal of pharmacology
Published: November 07, 2025
Microglial lipid droplets as therapeutic targets in age-related neurodegenerative diseases.
Journal: npj aging
Published: July 02, 2025
Mutations in NEK1 cause ciliary dysfunction as a novel pathogenic mechanism in amyotrophic lateral sclerosis.
Journal: Molecular neurodegeneration
Published: February 17, 2025
Graphene Quantum Dots Attenuate TDP-43 Proteinopathy in Amyotrophic Lateral Sclerosis.
Journal: ACS nano
Published: February 04, 2025
Tau reduction impairs nephrocyte function in Drosophila.
Journal: BMB reports
Published: January 05, 2025
Knockdown of glutathione S-transferase leads to mislocalization and accumulation of cabeza, a drosophila homolog of FUS, in the brain.
Journal: Journal of neurogenetics
Published: November 28, 2022
Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection.
Journal: Antioxidants (Basel, Switzerland)
Published: December 18, 2021
FUS-induced neurotoxicity is prevented by inhibiting GSK-3β in a Drosophila model of amyotrophic lateral sclerosis.
Journal: Human molecular genetics
Published: April 18, 2021
Dysfunction of Mitochondrial Dynamics in Drosophila Model of Diabetic Nephropathy.
Journal: Life (Basel, Switzerland)
Published: December 14, 2020
Recent Advances on the Role of GSK3β in the Pathogenesis of Amyotrophic Lateral Sclerosis.
Journal: Brain sciences
Published: August 20, 2020
Glutathione S-Transferase Rescues Motor Neuronal Toxicity in Fly Model of Amyotrophic Lateral Sclerosis.
Journal: Antioxidants (Basel, Switzerland)
Published: June 18, 2020
Last Updated: 09/26/2026